MYL1 and cancer: As illustrated in Figure 7B, KEGG analysis revealed significant enrichment of DEGs, including TPM1, MYL1, and MYH3, in pathways such as cytoskeleton in muscle cells, alanine aspartate and glutamate metabolism, cGMP-PKG signaling pathway, central carbon metabolism in cancer, and Th17 cell differentiation.